Wednesday, December 22, 2010 9:13 PM
|
CCSVI in Multiple Sclerosis
Pharma and the Mystery Mechanism With the devastating effects of Tysabri and PML in growing numbers of cases and the emergence of CCSVI research around the world, we are beginning to see a new marketing campaign in MS drugs-- the gradual move away from the autoimmune paradigm to potential (yet unproven) mechanisms. ...
|